安装 Steam
登录
|
语言
繁體中文(繁体中文)
日本語(日语)
한국어(韩语)
ไทย(泰语)
български(保加利亚语)
Čeština(捷克语)
Dansk(丹麦语)
Deutsch(德语)
English(英语)
Español-España(西班牙语 - 西班牙)
Español - Latinoamérica(西班牙语 - 拉丁美洲)
Ελληνικά(希腊语)
Français(法语)
Italiano(意大利语)
Bahasa Indonesia(印度尼西亚语)
Magyar(匈牙利语)
Nederlands(荷兰语)
Norsk(挪威语)
Polski(波兰语)
Português(葡萄牙语 - 葡萄牙)
Português-Brasil(葡萄牙语 - 巴西)
Română(罗马尼亚语)
Русский(俄语)
Suomi(芬兰语)
Svenska(瑞典语)
Türkçe(土耳其语)
Tiếng Việt(越南语)
Українська(乌克兰语)
报告翻译问题
The impetus for this decision was reports from Scandinavia of 30 serious blood clot events following the administering of five million doses of the vaccine in question which is manufactured by AstraZeneca, the British-Swedish multinational pharmaceutical company.
So is the vaccine safe? To answer that, we can look at the data from trials conducted on the vaccine before it was approved by the European Medicines Agency and other regulators. They showed an excellent safety profile and no evidence of induced blood clotting. And despite the current concerns, emerging data does not conclusively suggest any increase in clotting risk either.
-"Studley Mancannon" c.2021 17/03